More support for angioplasty vs thrombolysis
This article was originally published in Clinica
Mortality is lower among heart attack patients treated with primary angioplasty than among those who receive thrombolytic therapy, unless the hospital only performs a low volume of angioplasties, in which case there is no difference between the two groups. This is the conclusion of a 62,299-patient retrospective cohort study based at Colorado Permanente Medical Group and the University of Colorado Health Sciences Center in Denver, which was published in the December 27 issue of the Journal of the American Medical Association. The findings of the study will fuel the continuing debate about which type of treatment is more appropriate.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.